Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01643551 · ClinicalTrials.gov registry record
Neuron Specific Enolase in Ventricular Assist Device Recipients
A clinical trial, sponsored by University of Minnesota.
- Completed
- Registry status
- 15
- Enrollment target
NCT01643551: Completed study, sponsored by University of Minnesota.
NCT01643551 is a clinical trial that has completed, run by University of Minnesota. The registered enrollment target is 15 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01643551 has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- 15 participants
- Enrollment target
Study Summary
An observational study of neuron specific enolase, as a marker of reperfusion injury, in LVAD recipients before and following VAD implantation.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2012-06 |
| Est. Completion | 2013-07 |
What the finished NCT01643551 record still lists
NCT01643551 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 15 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01643551 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01643551 about?
NCT01643551 is a clinical study titled "Neuron Specific Enolase in Ventricular Assist Device Recipients". An observational study of neuron specific enolase, as a marker of reperfusion injury, in LVAD recipients before and following VAD implantation.
What is the current status of trial NCT01643551?
This trial is currently completed. The enrollment target is 15 participants. The study started on 2012-06. Estimated completion is 2013-07.
Who is sponsoring clinical trial NCT01643551?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia